ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryFinance & InsurancePrivate Equity & Venture CapitalWollerauLifeScience Investors Group AG
LifeScience Investors Group AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of LifeScience Investors Group AG is investing in and managing companies from the LifeScience sector, particularly in the pharmaceutical, biotechnology and medical technology segments. The company focuses on acquiring and developing companies that embody traditional corporate values and aims to pursue a sustainable growth strategy. The investments are made by experienced partners who are directly involved in the investment companies.

AI-generated
Offering

Products & services

Industry:Private Equity & Venture Capital
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
No score yet

LifeScience Investors Group AG

✓ Offered5
Private equity investments in the life sciences
Investments in companies and assets in pharma, medtech and life-science services, including equity-based investments, majority or qualified majority acquisitions, and long-term development.
Business succession and spin-off transactions
Advisory support for corporate spin-offs, carve-outs and succession solutions for private and group-owned companies, with a focus on strategic carve-outs and handovers.
Restructuring and turnaround support
Acquisition and repositioning of companies in special situations, including restructurings, operational problem cases, declining earnings, and regulatory or organisational issues.
Buy-and-build and company development
Strategic realignment, consolidation and buy-and-build approaches for the sustainable development of the investments, including strengthening growth and improving efficiency.
Management support and operational repositioning
Support from experienced managers, consultants and subject-matter specialists for strategic repositioning, adapting structure and processes, and strengthening finance, sales and production.
Trust & reputation

ranQ Trust Score of LifeScience Investors Group AG

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Media authority

Data basis 54% · As of October 2026

LifeScience Investors Group AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
LifeScience Investors Group AG scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
LifeScience Investors Group AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
LifeScience Investors Group AG scores 0.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.0.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 54%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once LifeScience Investors Group AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

LifeScience Investors Group AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank LifeScience Investors Group AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of LifeScience Investors Group AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Sihleggstrasse 23
8832 Wollerau

At a glance

Legal form
Corporation
UID
CHE-150.864.701
Founded
2011 · 15 years
Last commercial register change
January 19, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.100.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    CA
    Captum Advisors GmbH
    Wollerau
    VC
    Vireon Capital AG
    Wollerau
    AE
    AS Equity Partners Switzerland GmbH
    Pfäffikon Sz
    CM
    CGS Management AG
    Pfäffikon Sz
    AC
    AlphaInvest Capital Partners AG
    Altendorf
    AC
    Antares Capital Group KlG
    Pfäffikon Sz
    CP
    Castle Private Equity AG
    Pfäffikon Sz
    CE
    Cross Equity Partners AG
    Pfäffikon Sz